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Background/aim: Pregnant women and infants are at risk of severe lower respiratory tract infections induced by influenza or pertussis.
The uptake of both vaccines is poor in spite of proven benefits and safety. We aimed to determine the knowledge and attitude of pregnant
women and their primary healthcare providers towards immunization during pregnancy.
Materials and methods: This cross-sectional and interventional study was conducted in northern Turkey in 2016. It had 3 different
groups including 786 pregnant women, 146 primary healthcare staff, and 97 family practitioners. Different questionnaires were filled by
each group. The intervention phase of the study consisted of education of the expectant mothers about immunizations during pregnancy.
Results: 786 pregnant women aged between 17–44 years were enrolled to the study. Most of the participants had favourable attitude
about vaccination, but only 1.1% had influenza immunization, none had Tdap immunization. None of the participants joining the
intervention stage were immunized. The healthcare staff and family physicians had knowledge about vaccinations, but had abstention
for administration. Postexposure prophylaxis was also provided by referral centres.
Conclusions: Most of the participants either pregnant women or healthcare workers were not vaccinated against pertussis and influenza.
Dissemination of maternal immunization must be supported by the team work of healthcare professionals, authorities, universities,
professional associations, stake holders, media and patients with current, evidence based knowledge.
Key words: Immunization, pregnancy, influenza, adult type pertussis vaccine (Tdap), postexposure prophylaxis

1. Introduction
Women at childbearing age are typically immunized
against vaccine preventable diseases (VPD) through
vaccination or disease exposure [1,2]. However, immunity
may decrease over time and pregnant women or newborns become susceptible to VPD with complications.
[1,3]. Ideally, all women should be immunized before
pregnancy, but approximately 25% of pregnancies
are unplanned [4]. Maternal immunization provides
protection for the mother and baby until the primary
immunization schedule initiates [5]. Live attenuated
vaccines are contraindicated in pregnancy. Most inactive
vaccines are known to be safe and beneficial for maternal
and foetal health [1]. Maternal and neonatal tetanus has
been eradicated in many countries (including Turkey) by
tetanus-diphtheria (Td) vaccination during pregnancy [6].
This experience has been considered as an opportunity for

other VPD. There are increasing data showing maternal
immunization with inactive influenza (IIV) and adult type
tetanus, diphtheria, and acellular pertussis vaccine (Tdap)
is effective and safe to reduce severe respiratory tract
infections (RTI) [7,8]. Tdap and IIV are recommended
to pregnant women during every pregnancy, influenza at
any gestation age (preferably in the second trimester), and
Tdap during the third trimester for optimal transmission
of the maternal antibodies [7,9–12]. The expectant mother
is also protected from the disease, which may be more
complicated than nonpregnant peers. This provides a
“cocoon” around the infant during confinement. The
uptake of both vaccines is poor in spite of proven benefits.
Both pregnant women and their healthcare providers
are reluctant [5]. The Turkish Republic Ministry of
Health (TRMH) recommends routine Td and influenza
vaccinations for pregnant women according to adult
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vaccination schedules [13]. In Turkey, obstetrical follow
up is provided by obstetricians, family physicians, and
midwives in different healthcare settings. Vaccinations
are under the control of primary healthcare centres [13].
During pregnancy 97% of women receive antenatal care
from a healthcare provider at least once [4]. Therefore,
pregnancy becomes an opportunity for immunization.
In this study, we aimed to determine the knowledge and
attitude of pregnant women and their primary healthcare
providers towards immunization during pregnancy in
northern Anatolia. Also, we aimed to identify the factors
that affect the eventual decision on immunization. To
determine the potential barriers that could be addressed
for improving maternal immunization coverage, this
cross sectional, descriptive, and interventional study was
performed.
2. Materials and methods
The survey phase of the study was conducted in the
obstetrics outpatient clinics of a tertiary healthcare centre
between June 1st and December 31st 2016. Since the flu
season is between November and April in our country,
the duration of the study was planned to cover the flu and
vaccination season [14]. A questionnaire was prepared by
reviewing the literature for all pregnant women applying
to pregnancy follow-up unit. The questions were about
socio-demographic features (age, residence, educational
level, working status, occupation, and monthly income),
obstetric and medical history. General attitudes about
immunization, vaccination status at pregnancy, sources
of information, attitudes towards immunization during
pregnancy and general influenza vaccination status,
knowledge, and experience were documented. Reasons for
getting/not getting vaccinated during pregnancy were also
asked. The staff of the unit was educated about the survey.
The applicability of the questionnaire was tested with
20 pregnant women. Written and signed consent forms
of each participant were taken prior to administration.
Questionnaires were filled out with the help of staff
through face-to-face interviews lasting approximately 10
min.
In order to educate women about pregnancy and
baby care, childbirth education class were offered in
our hospital. The “intervention” phase of the study was
designed within this context. In addition to routine
pregnancy immunizations, a new course about influenza
and Tdap was added to the content, emphasizing that these
vaccines can be safely administered during pregnancy. At
the end of the study, participants of the course and survey
were called by telephone and asked whether they had
influenza and/or Tdap vaccines.
Assistant healthcare staff, midwives, nurses, and
health officials carrying out pregnancy follow-up

service in primary healthcare centres participated in the
study. They filled in the questionnaires via e-mail and
telephone calls. Age, gender, working place, and active
occupational time in the profession were asked. The
number of pregnant women was followed up, the rate of
follow up compliance, Td vaccination rate, acceptance
and rejection rates of vaccination and reasons, adverse
events after immunization, and personal thoughts about
immunization during pregnancy were questioned. Their
knowledge about vaccines and routine administration
(influenza, Tdap), and pregnancy immunization history of
their own or their partners’ were questioned.
Family physicians that carried out pregnancy followup service in primary healthcare centres also participated.
In the first part of the survey, information about age,
gender, work place, active working time in the profession,
number and pregnancy follow-up rate, Td immunization
rate, acceptance/rejection rates, nonroutine influenza and
Tdap vaccines justification, reasons for recommending/
not recommending, expert referral rate for immunization,
their immunization history during pregnancy, exposure
to vaccine preventable complications in pregnant women,
and their competence in vaccination were asked. In
the second part, physicians were asked to solve the case
scenarios about immunization during pregnancy when
indicated. Seven cases and 11 questions were scored as 1
point for every correct answer.
2.1. Ethics
The study was approved by the ethical committee of a
university with the decision number: 77082166-604.01.02.
2.2. Statistical analysis
Statistical analysis was performed using SPSS v15.0 (SPSS
Inc,, Chicago, IL, USA). The continuous variables were
investigated using visual/analytical methods. Descriptive
statistics were presented as frequencies, percentages,
arithmetical mean ± standard deviation, and median
(minimum, maximum). Categorical variables were
compared using Pearson’s chi-square, Yate’s corrected chisquare, and Fisher’s exact test where appropriate. Mann
Whitney-U test was used for the comparison of the 2
groups when the data were not normally distributed. A
P-value of less than 0.05 was considered as statistically
significant.
3. Results
A total of 786 pregnant women were enrolled in the study.
Their ages varied from 17 to 44 (mean: 26.83 ± 5.23)
years and the education level of 77.4% (n = 608) was at
least secondary level. Most of them were housewives
living at provincial area (n = 681, 86.6%; n = 406, 52.2%
respectively). Approximately 70% (n = 538) of the
participants were at the third trimester during the study
and 78.1% (n = 614) were followed up by an obstetrician.
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Td was administered to 77.4% (n = 608) of the
participants. Forty five (5.7%) participants avoided this
routine vaccine without a reason and 121 (15.5%) pregnant
women were in the early weeks of the first trimester to
get vaccinated. Fifty-five of the participants (10.8%) were
recommended influenza vaccination during pregnancy
and the source of recommendation was primary healthcare services in 47 (85.5%) patients. However only 8 (1.1%)
of them had influenza vaccination. Eleven participants
(1.5%) were recommended Tdap, but none of them got
vaccinated. The main reasons for not getting vaccinated
with influenza and Tdap during pregnancy were not
having sufficient knowledge about these immunizations or
not believing in their necessity.
Most of the participants had a favourable attitude
about vaccination in general and 57.5% (n = 449) thought
that the vaccines were necessary and beneficial for health.
Thirty-one (3.9%) pregnant women believed that vaccines
were unnecessary and unsafe. However, 31.6% (n = 248)
pregnant women had no sufficient general knowledge
about vaccines. Immunization during pregnancy was a
novel title which should be consulted with the attendee
physician. Most of the participants (n = 437; 63.5%) stated
that they would get vaccinated if their physician offered,
but 11.6% (n = 91) of them would never get vaccinated
during pregnancy. When the knowledge about the effect
of vaccines protecting the infants from severe respiratory

tract infections was shared, 81.4% (n = 637) of the
expectant mothers stated that they would get vaccinated.
In the “intervention phase” of the study, 142 participants
joining both the survey and childbirth education class
were called asked about immunization with influenza and/
or Tdap by phone. None of the participants got vaccinated
as their obstetricians did not recommend (Figure).
A total of 146 healthcare workers aged between 22
and 66 (mean: 34.26 ± 7.04) years old participated in the
survey. Nine were men and 24% (n = 35) was employed at
the provincial centre. The median occupational time was
10 years (1–40).
Encountering antivaccination attitude during
pregnancy was reported in the 24.7% of the study group.
Most common reasons were anxiety about side effects,
obstetricians’ statements about immunization, mistrust
to vaccines, personal belief in needlessness, pain/injection
fright, lack of knowledge, having been already vaccinated,
religions and medical reasons. However, pregnant women
religions persuaded by family physicians at prenatal visits,
provided Td vaccination rate as 94%. Only 4 (2.7%) of the
participants reported administration of hepatitis B and
influenza vaccines. One hundred and sixteen professionals
had pregnancy history and 105 (92.9%) were vaccinated
with Td, but only one had influenza immunization. Two
midwives experienced vaccine preventable complications
during pregnancy. Both cases were influenza complicated

Figure: The intervention phase of the study and results (page 6).

318

CELEP et al. / Turk J Med Sci
with severe lower RTI. Age, gender, occupational time,
and work place had no statistical significance on attitudes
about non-Td (influenza, Tdap) vaccinations during
pregnancy (P > 0.05).
Thirty-five women (36.1%) and 62 men (63.9%) from
a total of 97 family physicians aged between 25 and 61
years (mean 39.70 ± 7.70; median: 40) participated in
the study. The number of pregnant women followed up
was 4–45 (median 21), all attended prenatal visits at least
once. The rate of Td vaccination was 98%. In practice,
35% of the practitioners reported meeting vaccination
opposition. However, the final decision was the acceptance
of Td vaccination following the official recommendation
of TRMH. When asked about their own attitudes
towards non-Td immunizations, 43.3% (n = 42) reported
recommendation, 94% of these was influenza, 37.5%
Hepatitis B, and 14% Tdap. History of chronic illnesses
was an important factor (69.1%; n = 67). However, several
reasons for reluctance were also determined including lack
of routine practice, scepticism about necessity, worry about
side effects, and lack of education, desire to consult with
an expert, problem with risks, and those who were against
vaccination. Four of the physicians reported influenza
immunization during pregnancy. Socio-demographic
characteristics or immunization history had no effect on
non-Td vaccine recommendation (gender: P = 0.32; age:
P = 0.76; working place: P = 0.59; immunization history:
P = 0.09).
For postexposure prophylaxis or medical indication,
35.2% (n = 32) of physicians recommended vaccination
to pregnant women. In addition, 40.6% (n = 13) of these
physicians also recommended non-Td vaccines, but it was
not statistically significant. Needing expert consultation
for these administrations (53.7%; n = 29), reluctance to
take responsibility (16.7%; n = 9), complication follow-up
anxiety (13%; n = 7), and patient preference (7.4%; n = 4)
were reasons of referral to the advanced centre.
The mean score of physicians about case scenarios was
6.69 ± 0.26 points (out of 11 points) with a median of 7.00
(3–11; min-max). The 62.5% (n = 34) of the physicians
who scored above the average also recommended
immunization in case of medical necessity and non-Td
vaccines during pregnancy (Table).
4. Discussion
This study was designed to determine the attitude of
pregnant women and their primary healthcare providers
about immunizations during pregnancy. Of the 786
pregnant participants, 94% had Td, 1% had seasonal
influenza vaccine, and none had Tdap. Knowledge of
pregnant women about the process was insufficient and
the most important determinant of acceptance was the
recommendation of their attendee physician. Very few of

the healthcare personnel administered non-Td vaccines.
Although physicians had knowledge about immunizations
during pregnancy, they usually administered these
vaccines with expert consultation. The obstacles in the
field were the lack of information, the myths on side-effects
and the statements of obstetricians about immunization.
In this study, 50% of the pregnant women getting
influenza immunization were recommended by the family
physician and only 10% by obstetricians. Also, vaccination
rejection was prevented when immunization was officially
recommended or had been administered previously.
Thus, Td vaccination rates were above 90%, whereas the
rate of influenza vaccination was only 1%. Although the
risk class for teratogenicity of influenza and Tdap is C, the
awareness and acceptance rates were low among pregnant
women and healthcare workers. This result suggests that
habits rather than evidence based data are more effective
on attitude and behaviour development.
General attitude about vaccines is particularly
important in receiving immunization during pregnancy.
The most common reasons of rejection were insufficient
knowledge about vaccines, concerns about vaccine safety
and adverse effects, mistrust against vaccine efficacy, and
underestimation of disease risk [15–18]. Lack of knowledge
about immunizations during pregnancy seemed to be
the most important issue. The highest rate of influenza
immunization in Turkey during pregnancy was in the
2009–2010 pandemic influenza season (9.1%), which was
much lower than USA (45.7%). One reason for this high
rate may be due to the TRMH recommended vaccination
after the 20th gestational week [19,20]. Influenza
immunization rates are under desired levels in developed
countries. In a study conducted within the European
Union, vaccination rate in pregnant women in 2011/12
was reported as 2.0% in Slovenia and 30% in England. In
United States, this rate was 47% [16,21,22]. Differences
between countries may be related to different information,
communication techniques, formal vaccination schemes,
insurance coverage, and/or general vaccination attitudes.
Also, the earlier the influenza vaccine was added to the
pregnancy immunization schedule, the higher the rate of
vaccination would be. It has been administered in the US
since 1967; therefore, the vaccination rate is higher [23].
The formal recommendation was recently published by
the TRMH [24].
In this study, 8 of 786 pregnant women had an
influenza vaccine. The most common reasons for not
getting vaccinated was the lack of knowledge about the
vaccine (89.2%), thinking vaccination as unnecessary,
mistrust, unwillingness, and concerns about safety.
However, 63.5% of the participants declared that they
would accept vaccination if their physician recommended.
When the protective effect of immunization for the baby
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Table: The summary of case scenarios, management, and rate of family physicians’ correct answers (page 9) [1].
Case summary

A pregnant who needed to undergo splenectomy after acute
trauma

Immunization

Correct answer,
rate of correct answer (%)

Haemophilus influenza type b (Hib)

Yes,
49 % (n = 47)

Polysaccharide pneumococcal vaccine

Yes,
56.7% (n = 55)

Quadrivalent conjugated
Yes,
Meningococcal vaccine (Men ACWY)* 44.3% (n = 43)
Immunization of a pregnant woman planning to pilgrimage

Quadrivalent conjugated
Meningococcal vaccine (Men ACWY)

Yes,
46.4% (n = 45)

Postexposure prophylaxis for rabies after a dog bite

Rabies vaccine

Yes,
78.4% (n = 76)

Serology negative pregnant woman’s susceptible exposure to
chickenpox

Varicella vaccination

No **
79.2% (n = 76)

Rubella immunization consultation of a serology negative
pregnant woman to prevent congenital rubella syndrome

Rubella vaccination

No **
74.7 % (n =71)

Improper vaccination hepatitis B schedule of a nurse

Hepatitis B immunization

Yes
65.6 % (n = 63)

Hepatitis A vaccination of a seronegative pregnant woman

Hepatitis A immunization

No ***
%38.9 (n = 37)

Poliomyelitis immunization of pregnant woman whose
vaccination schedule is incomplete for polio and obliged to
visit Afghanistan as a United Nations officer

Inactive poliomyelitis vaccine

Yes
%57 (n = 53)

Oral polio vaccine

No
58.5% (n = 55)

*no data is available for MenB vaccines; the situation should be evaluated individually.
**should be postponed to postpartum period.
***should be postponed to postpartum period if there is no risk factors, susceptible exposure or an epidemic.

was declared, the acceptance rate raised to 81.4%, which
is consistent with the literature [5,19]. Although living in a
city was a facilitating factor, it was striking that none of the
vaccinated women of this study lived in the city [17,25].
All of them had secondary or higher grade education
supporting that vaccination rates were increased when
education level increased [19,20,26].
In the intervention phase of the study, a lecture
providing awareness for the participants was given about
immunization during pregnancy. However, since the
lecture did not come from their physician, none received
the vaccine. Informing pregnant women and pointing
baby’s health through physicians are important variables
for increasing vaccination [27].
Lack of knowledge about immunization during
pregnancy is typically uncommon in developed countries.
Several reasons for vaccine rejection in those studies study
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include; pre-existing treatment options already available
for influenza, no serious disease threat, vaccination
causing flu, trypanophobia, mother/baby concern, lack
of trust in healthcare and vaccine efficacy, media bias,
lack of information vaccine locations, and financial
burden. Strategies to increase vaccination consent include;
education, make certain inter-sectored support, allotted
time for caregivers to educate patients on vaccinations
during visit, make increased vaccines accessibility,
disseminate education/propaganda on vaccinations,
enhance reliability of sources for dissemination, alter
legislation, and increase methods for side-effect reduction
[5,28]. Although the general vaccination and Td rates are
high, 27.4% of the healthcare personnel reported rejection
due to the same reasons listed above. A lot of physicians
(43%) recommended nonroutine vaccines to pregnant
women. However, the rate was lower than developed
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countries and the most common recommended non-Td
vaccine was influenza. Presence of chronic disease, history
of influenza vaccination during pregnancy by physician,
the belief in the cocooning strategy, and knowledge about
vaccinations were factors increasing the vaccination
recommendation rate. The reasons for not offering non-Td
immunizations were also reported and included; religious
beliefs, scepticism of vaccinations, concerns about baby’s
health following vaccination, lack of proper education
about pregnancy and vaccinations, and expecting the
requisition from the patient. This problem can be solved
by official application formulas from the ministry, as in
the case of Belgium and Canada [26,29]. Epidemics or
dramatic events like in 2009 change the attitude of people.
In general, immunization seems to be the responsibility
of primary care services. In Spain, pregnancy follow-up is
usually provided by the primary care units. Midwives are
the main source of immunization information. Influenza
immunization rate was reported as 40.5% [29,30]. In this
study, the main source of recommendation was primary
caregivers rather than obstetricians. Studies in the literature
focus on the abstention of gynaecologists in practice and
guidance rather than lack of knowledge. We obtained the
data about obstetricians’ attitudes indirectly as the study
was designed for primary caregivers, which is a limitation
of this study. The literature data and the statements of the
medical staff overlap; there is a lot of information pollution
and abstention caused by traditionalist tendency [29]. Tdap
has been recommended during pregnancy in developed
countries recently. In this study, none of the participants
got Tdap. The awareness of assistant healthcare personnel
was low (3.4%) and recommendation rate of physicians was
14% (n = 6). Tdap is a new vaccine in Turkey. False beliefs
that history of whooping cough and/or immunization
during childhood provide permanent immunization
causing no vaccination coverage. Tdap in pregnancy has
not been studied in Turkey. However, a survey conducted
in Belgium in 2014–2015 showed that the rate of Tdap
immunization was 65%. Interestingly, 82.4% of this was
recommended by family physicians. The most important
factor facilitating acceptance was the expectant mother’s
education level [26]. Since 2004, Immunization Advisory
Committee in Germany has recommended immunization
to all women of childbearing age, to all adults who may
be in close contact with babies, and those that have not
been vaccinated with Tdap in the last 10 years (cocooning
strategy). Tdap is offered before pregnancy or during
postpartum period, whereas it is routine in England and
USA during pregnancy. The immunization rate was high
in England, but low (1.7%) in Italy [31,32]. Cocooning
strategy is supported, but it is difficult to apply in practice.
Therefore, it cannot replace, but support maternal
immunization [33,34].

Postexposure prophylaxis is also possible for pregnant
women. This problem seems to be solved by infectious
diseases experts in referral healthcare centres. In this study,
56.7% of physicians recommended and administered
post exposure prophylaxis during pregnancy. No studies
evaluating the knowledge and attitude of the physicians’
on postexposure prophylaxis have been found in the
literature.
Immunization during pregnancy is beneficial and
safe for the mother and the baby. In spite of all evidencebased benefits, the process creates hesitation for pregnant
women and healthcare providers. Td rates are above
90%, but influenza and Tdap during pregnancy are much
lower than expected both in our province and in Turkey.
The reasons for this problem are the lack of current and
evidence-based information, the fact that obstetricians
do not recommend immunization, and insufficient
time for explaining vaccines to patients. Education and
encouragement of physicians with current information
can contribute positively to the process. A common
thought is that distribution of information by obstetricians
would assist in consent. Alternative protective methods for
immunization are not as effective as vaccination for clinical
protection, feasibility, and cost effectiveness. Cocooning
via herd immunity is protective for the woman/child but,
it has several limitations.
Education and administration of vaccinations during
pregnancy need to be implemented and funded during
follow-up visits. Support for these programs should
be encouraged by our institutions, caregivers, and
legislators. Financial support by social security services
will be important for distributing information about
immunizations during pregnancy.
A single dose of influenza vaccine should be
recommended to all women planning pregnancy and
for those expecting in their second trimester during the
influenza season. Also Td dose closest to birth should be
given as Tdap to protect the infant from pertussis related
lower RTI. The common outcome of all
 studies is that
healthcare providers should recommend vaccination for
the acceptance of pregnant women.
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